These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 19433386

  • 21. [Aromatase inhibitors in the adjuvant treatment of postmenopausal patients with early breast cancer: a little, a lot or no way?].
    Perey L, Zaman K.
    Rev Med Suisse; 2007 Oct 24; 3(130):2406, 2408-10, 2412. PubMed ID: 18062504
    [Abstract] [Full Text] [Related]

  • 22. Management of bone loss induced by aromatase inhibitors.
    Gnant M.
    Cancer Invest; 2006 Oct 24; 24(3):328-30. PubMed ID: 16809162
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer.
    Vestergaard P, Rejnmark L, Mosekilde L.
    Calcif Tissue Int; 2008 May 24; 82(5):334-40. PubMed ID: 18463912
    [Abstract] [Full Text] [Related]

  • 26. Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis.
    Hadji P.
    Crit Rev Oncol Hematol; 2009 Jan 24; 69(1):73-82. PubMed ID: 18757208
    [Abstract] [Full Text] [Related]

  • 27. Aromatase inhibitors and bone.
    Eastell R.
    J Steroid Biochem Mol Biol; 2007 Jan 24; 106(1-5):157-61. PubMed ID: 17643293
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Update on identifying and managing osteoporosis in women with breast cancer.
    Yamamoto DS, Viale PH.
    Clin J Oncol Nurs; 2009 Oct 24; 13(5):E18-29. PubMed ID: 19793700
    [Abstract] [Full Text] [Related]

  • 31. Long-term effects of aromatase inhibitors on bone.
    Eastell R, Hannon R.
    J Steroid Biochem Mol Biol; 2005 May 24; 95(1-5):151-4. PubMed ID: 15970439
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Phase 3 trials of aromatase inhibitors for breast cancer prevention: following in the path of the selective estrogen receptor modulators.
    Dunn BK, Ryan A.
    Ann N Y Acad Sci; 2009 Feb 24; 1155():141-61. PubMed ID: 19250201
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of bone loss associated with breast cancer: a review].
    Shao J, Gong YP.
    Ai Zheng; 2008 Feb 24; 27(2):218-22. PubMed ID: 18279626
    [Abstract] [Full Text] [Related]

  • 36. Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
    Gnant M, Dubsky P, Fitzal F, Blaha P, Schoppmann S, Steger G, Marth C, Samonigg H, Hüttner K, Fohler H, Ruecklinger E, Jakesz R, Greil R, Austrian Breast and Colorectal Cancer Study Group.
    Clin Breast Cancer; 2009 Jun 24; 9 Suppl 1():S18-27. PubMed ID: 19561003
    [Abstract] [Full Text] [Related]

  • 37. Bone loss and the aromatase inhibitors.
    Lester J, Coleman R.
    Br J Cancer; 2005 Aug 24; 93 Suppl 1(Suppl 1):S16-22. PubMed ID: 16100521
    [Abstract] [Full Text] [Related]

  • 38. Vitamin D supplementation and response to aromatase inhibitors in postmenopausal women with hormone-receptor positive breast cancer.
    Dizdar O, Bulut N, Altundag K.
    Breast; 2008 Apr 24; 17(2):120. PubMed ID: 18037293
    [No Abstract] [Full Text] [Related]

  • 39. A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer.
    Liang E, Beshara M, Sheng H, Huang XW, Roh JM, Laurent CA, Lee C, Delmerico J, Tang L, Lo JC, Hong CC, Ambrosone CB, Kushi LH, Kwan ML, Yao S.
    Breast Cancer Res Treat; 2024 Nov 24; 208(2):349-358. PubMed ID: 38976164
    [Abstract] [Full Text] [Related]

  • 40. Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition.
    Van Poznak C.
    Breast Cancer Res; 2010 Nov 24; 12(3):110. PubMed ID: 20584345
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.